Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,426 | $2,125 | $34,439 | $34,439 |
| - Cash | $11,435 | $8,059 | $10,516 | $10,882 |
| + Debt | $5,848 | $5,949 | $10,490 | $10,586 |
| Enterprise Value | -$1,161 | $14 | $34,413 | $34,143 |
| Revenue | $4,106 | $4,311 | $5,389 | $21,859 |
| % Growth | -4.8% | -20% | -75.3% | – |
| Gross Profit | $2,847 | $1,912 | $3,663 | $14,617 |
| % Margin | 69.3% | 44.4% | 68% | 66.9% |
| EBITDA | -$1,113 | -$1,870 | -$1,234 | -$14,595 |
| % Margin | -27.1% | -43.4% | -22.9% | -66.8% |
| Net Income | -$7,278 | -$3,321 | -$2,670 | -$7,904 |
| % Margin | -177.3% | -77% | -49.5% | -36.2% |
| EPS Diluted | -4.87 | -19.69 | -0.23 | -0.68 |
| % Growth | 75.3% | -8,460.9% | 66.2% | – |
| Operating Cash Flow | -$624 | -$905 | -$449 | -$4,250 |
| Capital Expenditures | $1,517 | $289 | -$64 | -$36 |
| Free Cash Flow | $893 | -$617 | -$513 | -$4,287 |